84 related articles for article (PubMed ID: 19698583)
1. Clinical measures of rapid onset of action.
Montgomery SA
Eur Psychiatry; 1997; 12 Suppl 4():295s-300s. PubMed ID: 19698583
[TBL] [Abstract][Full Text] [Related]
2. A review of the efficacy and tolerability of venlafaxine.
Dierick M
Eur Psychiatry; 1997; 12 Suppl 4():307s-13s. PubMed ID: 19698585
[TBL] [Abstract][Full Text] [Related]
3. Rapid onset of action of venlafaxine.
Montgomery SA
Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():21-7. PubMed ID: 7622814
[TBL] [Abstract][Full Text] [Related]
4. The role of venlafaxine in rational antidepressant therapy.
Feighner JP
J Clin Psychiatry; 1994 Sep; 55 Suppl A():62-8; discussion 69-70, 98-100. PubMed ID: 7961545
[TBL] [Abstract][Full Text] [Related]
5. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
Serres F; Millan MJ; Sharp T
Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic action lag time and resistance to treatment].
Peretti CS
Encephale; 1999 Jun; 25 Spec No 2():49-54. PubMed ID: 10434159
[TBL] [Abstract][Full Text] [Related]
7. Neurobiologic basis of antidepressant safety profiles.
Hackett D; Salinas E
Eur Psychiatry; 1997; 12 Suppl 4():301s-6s. PubMed ID: 19698584
[TBL] [Abstract][Full Text] [Related]
8. Global Benefit-risk Evaluation of Antidepressant Action: Comparison of Pooled Data for Venlafaxine, SSRIs, and Placebo.
Entsuah R; Gao B
CNS Spectr; 2002 Dec; 7(12):882-888. PubMed ID: 12766699
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutic profile of venlafaxine.
Preskorn S
Eur Psychiatry; 1997; 12 Suppl 4():285s-94s. PubMed ID: 19698582
[TBL] [Abstract][Full Text] [Related]
10. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
Fava GA; Benasi G; Lucente M; Offidani E; Cosci F; Guidi J
Psychother Psychosom; 2018; 87(4):195-203. PubMed ID: 30016772
[TBL] [Abstract][Full Text] [Related]
11. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine: a structurally unique and novel antidepressant.
Morton WA; Sonne SC; Verga MA
Ann Pharmacother; 1995 Apr; 29(4):387-95. PubMed ID: 7633018
[TBL] [Abstract][Full Text] [Related]
13. Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Dhir A; Kulkarni SK
Neurosci Lett; 2008 Nov; 445(1):83-8. PubMed ID: 18778754
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
Holliday SM; Benfield P
Drugs; 1995 Feb; 49(2):280-94. PubMed ID: 7729333
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine:a novel antidepressant compound.
Schweizer E; Thielen RJ; Frazer A
Expert Opin Investig Drugs; 1997 Jan; 6(1):65-78. PubMed ID: 15989562
[TBL] [Abstract][Full Text] [Related]
16. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
17. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
Rudolph RL; Fabre LF; Feighner JP; Rickels K; Entsuah R; Derivan AT
J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154
[TBL] [Abstract][Full Text] [Related]
19. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
Thase ME
J Clin Psychiatry; 1998 Oct; 59(10):502-8. PubMed ID: 9818630
[TBL] [Abstract][Full Text] [Related]
20. Remission from depression : a review of venlafaxine clinical and economic evidence.
Han D; Wang EC
Pharmacoeconomics; 2005; 23(6):567-81. PubMed ID: 15960553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
